Skip to main content
Deutsche Biotech Innovativ AG logo

Deutsche Biotech Innovativ AG — Investor Relations & Filings

Ticker · DBI ISIN · DE000A0Z25L1 LEI · 391200BIDNL2ZOKI1M61 F Manufacturing
Open in API
Filings indexed 67 across all filing types
Latest filing 2025-11-18 Audit Report / Informat…
Country DE Germany
Listing F DBI

About Deutsche Biotech Innovativ AG

https://www.dbi-ag.de/

Deutsche Biotech Innovativ AG is a biotechnology company focused on the research and clinical development of therapeutic solutions for serious diseases. The company utilizes innovative blood biomarkers to guide its development process. Its lead product candidate is Adrecizumab, a monoclonal, adrenomedullin-specific antibody designed to treat conditions involving endothelial barrier dysfunction. Adrecizumab has completed Phase I/II clinical trials for the treatment of septic shock.

Recent filings

Filing Released Lang Actions
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Deutsche Biotech Innovativ AG for the fiscal year 2024. It contains a balance sheet (Bilanz), notes (Anhang), and management disclosures. While it is not a full 10-K (which is a US-specific term), it functions as the official annual financial report for a German entity. In the provided taxonomy, '10-K' is the designated category for official yearly reports covering company activity and full financial performance, making it the most appropriate fit for this annual financial statement. FY 2024
2025-11-18 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 95% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for TDT AG for the fiscal year 2024. It contains a balance sheet (Bilanz), notes to the financial statements (Anhang), and details regarding the company's management and accounting principles. While it is a German statutory filing, it functions as the comprehensive annual financial report for the company. Given the definitions provided, it aligns best with the '10-K' category, which covers official yearly reports of company activity and financial performance. FY 2024
2025-09-29 German
Datum:29.09.2025
Annual Report Classification · 95% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for TDT AG for the fiscal year 2024. It includes a balance sheet (Bilanz), notes to the financial statements (Anhang), and details regarding the company's management and accounting principles. While it is an annual financial document, it is a standalone statutory financial statement rather than a comprehensive 10-K style annual report. In the context of German corporate filings, this is classified as an Annual Report/Financial Statement. Given the provided categories, '10-K' is the most appropriate fit for a full annual financial statement. FY 2024
2025-09-29 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for TDT AG for the fiscal year 2023. It contains a balance sheet (Bilanz), notes (Anhang), and details regarding the company's accounting principles and management. While it is not a full 10-K (which is a specific US SEC filing), it functions as the official annual financial report for a German entity. Given the provided categories, '10-K' is the most appropriate classification for a comprehensive annual financial report. FY 2023
2024-10-08 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Annual Report Classification · 95% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Deutsche Biotech Innovativ AG for the fiscal year 2023. It contains a balance sheet (Bilanz), notes to the financial statements (Anhang), and management disclosures. While it is an annual report, it is a standalone financial statement filing rather than a comprehensive 10-K style annual report with extensive narrative analysis. In the context of the provided categories, this fits the definition of an Annual Report (10-K) as it represents the official yearly financial performance report. FY 2023
2024-10-07 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report Classification · 100% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for the fiscal year 2022, including a balance sheet ('Bilanz'), notes ('Anhang'), and management disclosures. It contains substantive financial data and is not merely an announcement or a certification. In the context of global financial reporting, a comprehensive annual financial statement for a company is classified as an Annual Report (10-K). FY 2022
2023-12-20 German

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.